Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

5-fluorouracil-hyaluronic acid complex - Alchemia

Next Previous
Search
Drug Profile

5-fluorouracil-hyaluronic acid complex - Alchemia

Alternative Names: 5-fluorouracil hyaluronan acid complex; HA-5-fluorouracil; HA-5FU; Hyaluronan acid-5-fluorouracil complex; Hyaluronic acid-5-fluorouracil complex

Latest Information Update: 11 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Alchemia
  • Class Antineoplastics; Pyrimidinones; Small molecules
  • Mechanism of Action DNA synthesis inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Colorectal cancer

Most Recent Events

  • 23 Jan 2018 No development reported - Phase-I/II for Colorectal cancer (Metastatic disease) in Australia (IV)
  • 01 Dec 2015 Phase-I/II clinical trials in Colorectal cancer in Australia (IV) prior to December 2015
  • 01 Dec 2015 Efficacy and adverse event data from a phase I/II trial released by Alchemia (Alchemia pipeline, December 2015) prior to December 2015

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top